{ "items": [ "\n\n
\n \n 17 June 2020\n \n
\n\n \n\n \n\n \n \n \n \n Awards\n \n \n\n \n\n\n
\n \n\n \n \n \nChristopher Buckley, Kennedy Professor of Translational Rheumatology at the University of Oxford and Birmingham, has been awarded the 2020 Carol Nachman prize for Rheumatology.
\n \n\n\n \n 11 June 2020\n \n
\n\n \n \n \n\n \n \n \n \n \n\n\n \n 10 June 2020\n \n
\n\n \n \n \n\n \n \n \nThe Arthritis Therapy Acceleration Programme (A-TAP), led by the Kennedy Institute in Oxford and the Institute of Inflammation and Ageing in Birmingham, provides support for the new CATALYST Trial to investigate whether administering the anti-inflammatory drug infliximab to patients with COVID-19 can prevent progression to respiratory failure or death.
\n \n\n\n \n 4 June 2020\n \n
\n\n \n \n \n\n \n \n \nResearch at the Kennedy Institute reveals sub-populations of stromal cells with distinct functions in human fibrotic disease. These findings could inform development of more specific therapies with fewer off-target effects.
\n \n\n\n \n 23 May 2020\n \n
\n\n \n \n \n\n \n \n \nPublished in Science Immunology, researchers at the Kennedy Institute have identified the role of IRF5 in controlling intestinal inflammation.
\n \n\n\n \n 14 May 2020\n \n
\n\n \n \n \n\n \n \n \nThe research will test innovative technology that harnesses the body\u2019s intrinsic immune system to transform the treatment of cancer and autoimmune diseases.
\n \n\n\n \n 11 May 2020\n \n
\n\n \n \n \n\n \n \n \nResearchers in the Dustin Group reveal supramolecular attack particles are autonomous killing entities released from cytotoxic T lymphocytes
\n \n\n\n \n 30 April 2020\n \n
\n\n \n \n \n\n \n \n \nA number of members of the department are actively helping with the response to the COVID pandemic. Playing a key role in research, literature reviews, clinical trials and engineering projects, all have a shared commitment to collaborate globally to tackle the pandemic.
\n \n\n\n \n 30 April 2020\n \n
\n\n \n\n \n\n \n \n \n \n Funding\n \n \n\n \n\n\n
\n \n\n \n \n \n \n \n\n\n \n 29 April 2020\n \n
\n\n \n\n \n\n \n \n \n \n Department\n \n \n\n \n\n\n
\n \n\n \n \n \nFiona was recognised for her outstanding contributions to immunology, and her election brings the number of current National Academy of Sciences members from the Kennedy Institute to three.
\n \n\n\n \n 16 April 2020\n \n
\n\n \n \n \n\n \n \n \nResearch from Tal Arnon\u2019s group at the Kennedy Institute reveals a network of perivascular pathways that guide T cells into the spleen.
\n \n\n\n \n 20 March 2020\n \n
\n\n \n\n \n\n \n \n \n \n Department\n \n \n\n \n\n\n
\n \n\n \n \n \nNDORMS announces the closure of the Kennedy and Botnar Institutes and outlines other plans and activities for the department during the pandemic.
\n \n\n\n \n 9 March 2020\n \n
\n\n \n\n \n\n \n \n \n \n General\n \n \n\n \n\n\n
\n \n\n \n \n \nMolecular changes in the joint fluid during surgical joint distraction reveal markers that may drive cartilage repair in osteoarthritis.
\n \n\n\n \n 21 February 2020\n \n
\n\n \n\n \n\n \n \n \n \n Funding\n \n \n\n \n\n\n
\n \n\n \n \n \nInvestigators based at the Kennedy Institute of Rheumatology, NDORMS have recently received CRUK awards to increase understanding of a variety of cancers and immunotherapy.
\n \n\n\n \n 31 January 2020\n \n
\n\n \n \n \n\n \n \n \nDr Fiona Watt and Professor Stephanie Dakin announced as Associate Professors
\n \n\n\n \n 27 January 2020\n \n
\n\n \n \n \n\n \n \n \nNDORMS researchers join five other universities to investigate how cancer survivors make antibodies that target and destroy tumours, and explore routes for new treatments
\n \n\n\n \n 20 January 2020\n \n
\n\n \n \n \n\n \n \n \nA new study published in Nature Communications identifies a key driver of joint and intestinal inflammation that could lead to future treatment of the chronic inflammatory disease.
\n \n\n\n \n 15 January 2020\n \n
\n\n \n \n \n\n \n \n \nResearchers have uncovered how tumors exploit tenascin-C to deflect the body\u2019s natural defence against them.
\n \n\n\n \n 6 December 2019\n \n
\n\n \n \n \n\n \n \n \nA new study published in the Journal of Experimental Medicine reveals how IL-10 and PGE2 work together to prevent inflammatory tissue damage and maintain a healthy gut balance
\n \n\n\n \n 12 November 2019\n \n
\n\n \n\n \n\n \n \n \n \n Awards\n \n \n\n \n\n\n
\n \n\n \n \n \nJagdeep Nanchahal, Professor of Hand, Plastic and Reconstructive Surgery at the Kennedy Institute, and his team have won the International Dupuytren Award for a trial repurposing anti-TNF in Dupuytren\u2019s disease.
\n \n\n